A decrease in the tear secretion volume in a mouse model with ulcerative colitis

References

• Schein OD, Muñoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723–728.
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BEK. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264–1268.
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318–326.
   PubMed Web of Science ®Google Scholar
• Miljanović B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409–415.
   PubMed Web of Science ®Google Scholar
• Perry HD. Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care 2008;14:S79–S87.
   PubMed Web of Science ®Google Scholar
• Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int 2015;112:71–81.
   PubMed Web of Science ®Google Scholar
• Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001;45:S203–S210.
   PubMed Web of Science ®Google Scholar
• De Paiva CS. Effects of aging in dry eye. Int Ophthalmol Clin 2017;57:47–64.
   PubMedGoogle Scholar
• Uchino M, Schaumberg DA, Dogru M, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 2008;115:1982–1988.
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Buring JE, Sullivan DA, et al. Hormone replacement therapy and dry eye syndrome. JAMA 2001;286:2114–2119.
   PubMed Web of Science ®Google Scholar
• Murube J, Németh J, Höh H, et al. The triple classification of dry eye for practical clinical use. Eur J Ophthalmol 2005;15:660–667.
   PubMed Web of Science ®Google Scholar
• Yazdani-Ibn-Taz MK, Han MM, Jonuscheit S, et al. Patient-reported severity of dry eye and quality of life in diabetes. Clin Ophthalmol 2019;13:217–224.
   PubMed Web of Science ®Google Scholar
• Sartor RB. The intestinal microbiota in inflammatory bowel diseases. In: Lewis JD, Ruemmele FM, Wu GD, eds. Nutrition, gut microbiota and immunity: therapeutic targets for IBD. New York, NY: 79th Nestlé Nutrition Institute Workshop; 2014. p. 29–39.
   Google Scholar
• Wang W, Jovel J, Halloran B, et al. Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis 2015;21:1419–1427.
   PubMed Web of Science ®Google Scholar
• Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014;14:329–342.
   PubMed Web of Science ®Google Scholar
• Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011;7:235–241.
   PubMedGoogle Scholar
• Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2015;21:1982–1992.
   PubMed Web of Science ®Google Scholar
• Felekis T, Katsanos K, Kitsanou M, et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis 2009;15:29–34.
   PubMed Web of Science ®Google Scholar
• Oltulu P, Oltulu R, Asil M, et al. Conjunctival impression cytology and dry eye in patients with ulcerative olitis: a pilot study. Eye Contact Lens 2018;44:S190–S193.
   PubMed Web of Science ®Google Scholar
• Williamson J, Gibson AAM, Wilson T, et al. Histology of the lacrimal gland in keratoconjunctivitis sicca. Br J Ophthalmol 1973;57:852–858.
   PubMed Web of Science ®Google Scholar
• Kang EH, Lee YJ, Hyon JY, et al. Salivary cytokine profiles in primary Sjogren’s syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1/Th-2 ratios. Clin Exp Rheumatol 2011;29:970–976.
   PubMed Web of Science ®Google Scholar
• Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res 2006;82:885–898.
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Hiramoto K, Koyama M, et al. Impairment of skin barrier function via cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model. Exp Dermatol 2015;24:779–784.
   PubMed Web of Science ®Google Scholar
• Kondo K, Hiramoto K, Yamate Y, et al. Ameliorative effect of high-dose vitamin C administration on dextran sulfate sodium-induced colitis mouse model. Biol Pharm Bull 2019;42:954–959.
   PubMed Web of Science ®Google Scholar
• Chassaing B, Aitken JD, Malleshappa M, et al. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 2014;104:15–25.
   PubMedGoogle Scholar
• Lorentsen JK, Hendrix CW, Collins JM, et al. Dextran sulfate is poorly absorbed after oral administration. Ann Intern Med 1989;111:561–566.
   PubMed Web of Science ®Google Scholar
• Lin Z, Liu X, Zhou T, et al. A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis 2011;17:257–264.
   PubMed Web of Science ®Google Scholar
• Tapinos NI, Polihronis M, Tzioufas AG, et al. Immunopathology of Sjögren’s syndrome. Ann Med Interne 1998;149:17–24.
   PubMedGoogle Scholar
• Yokoyama S, Hiramoto K, Koyama M, et al. Chronic liver injury in mice promotes impairment of skin barrier function via tumor necrosis factor-alpha. Cutan Ocul Toxicol 2016;35:194–203.
   PubMed Web of Science ®Google Scholar
• Ushio A, Arakaki R, Eguchi H, et al. Pathological analysis of ocular lesions in a murine model of Sjögren’s syndrome. Ijms 2017;18:1209.
   Google Scholar
• Tsubota K, Hirai S, King LS, et al. Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren’s syndrome. Lancet 2001;357:688–689.
   PubMed Web of Science ®Google Scholar
• Ding C, Nandoskar P, Lu M, et al. Changes of aquaporins in the lacrimal glands of a rabbit model of Sjögren’s syndrome. Curr Eye Res 2011;36:571–578.
   PubMed Web of Science ®Google Scholar
• Raina S, Preston GM, Guggino WB, et al. Molecular cloning and characterization of an aquaporin cDNA from salivary, lacrimal, and respiratory tissues. J Biol Chem 1995;270:1908–1912.
   PubMed Web of Science ®Google Scholar
• Towne E, Krane CM, Bachurski CJ, et al. Tumor necrosis factor-alpha inhibits aquaporin 5 expression in mouse lung epithelial cells . J Biol Chem 2001;276:18657–18664.
   PubMed Web of Science ®Google Scholar
• Yamamura Y, Motegi K, Kani K, et al. TNF-α inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation. J Cell Mol Med 2012;16:1766–1775.
   PubMed Web of Science ®Google Scholar